Cancer's Cloak of Invisibility
Nagalase is an enzyme that plays a significant role in cancer, Lyme disease, Epstein-Barr virus, and other chronic debilitating infections. It is an immunosuppressive enzyme that hinders the immune system’s ability to detect and destroy mutated and infected cells, allowing them to replicate and spread.
Nagalase weakens the immune response by decreasing the production of an immune-stimulating molecule called Gc-MAF. It does this by breaking down Gc-MAF’s precursor protein (called Gc-protein or vitamin D binding protein), preventing it from being turned into Gc-MAF. When this happens, the immune system fails to recognize and attack destructive and diseased cells, allowing them to continue growing and spreading. For this reason, nagalase is sometimes called cancer’s cloak of invisibility.
Cancer cells, Lyme bacteria, and certain viruses produce nagalase as part of their survival strategy. Understanding of this has led to better options for natural treatments that will support the immune system instead of tearing it down. Nagalase can be detected through a simple blood test, and if levels are elevated they can be treated with a specific substance called Salicinium.